Logo image of PODD

INSULET CORP (PODD) Stock Overview

NASDAQ:PODD - US45784P1012 - Common Stock

331.79 USD
-0.04 (-0.01%)
Last: 8/27/2025, 9:46:25 AM

PODD Key Statistics, Chart & Performance

Key Statistics
52 Week High334.18
52 Week Low199.69
Market Cap23.35B
Shares70.39M
Float70.12M
Yearly DividendN/A
Dividend YieldN/A
EPS(TTM)4.23
PE78.44
Fwd PE56.35
Earnings (Next)11-05 2025-11-05/amc
IPO05-15 2007-05-15
Sector
GICS SectorHealth Care
GICS IndustryHealth Care Equipment & Supplies
GICS IndustryGroupHealth Care Equipment & Services
GICS SubIndustryHealth Care Equipment


PODD short term performance overview.The bars show the price performance of PODD in the last week, last 2 weeks, last month, last 3 and 6 months. 1 week 2 week 1 month 3 months 6 months 5 10 15 20

PODD long term performance overview.The bars show the price performance of PODD in the last 1, 2 and 3 years. 1 year 2 years 3 years 20 40 60

The current stock price of PODD is 331.79 USD. In the past month the price increased by 13.84%. In the past year, price increased by 63.65%.

INSULET CORP / PODD Daily stock chart

PODD Competitors/Peers

The largest stocks on the US markets in the "Health Care Equipment" sub-industry
Full List
Symbol
Company Name
TA
FA
PE
Market Cap
ABT ABBOTT LABORATORIES 26.81 228.64B
ISRG INTUITIVE SURGICAL INC 58.69 169.37B
BSX BOSTON SCIENTIFIC CORP 37.6 157.65B
SYK STRYKER CORP 30.69 150.75B
MDT MEDTRONIC PLC 16.64 117.90B
BDX BECTON DICKINSON AND CO 13.63 55.73B
IDXX IDEXX LABORATORIES INC 53.5 51.40B
EW EDWARDS LIFESCIENCES CORP 31.62 47.70B
RMD RESMED INC 29.54 41.30B
GEHC GE HEALTHCARE TECHNOLOGY 15.96 33.95B
DXCM DEXCOM INC 44.42 29.62B
PHG KONINKLIJKE PHILIPS NVR- NY 16.42 26.56B

About PODD

Company Profile

PODD logo image Insulet Corp. is a medical device company, which engages in the development, manufacture, and marketing of an insulin infusion system for people with insulin-dependent diabetes. The company is headquartered in Acton, Massachusetts and currently employs 3,900 full-time employees. The company went IPO on 2007-05-15. The company is primarily engaged in the development, manufacture and sale of its continuous insulin delivery systems for people with insulin-dependent diabetes. The Omnipod System includes the Omnipod 5 Automated Insulin Delivery System (Omnipod 5), the Omnipod DASH Insulin Management System, the Omnipod Insulin Management System, and Omnipod GO. The company also produces pods for Amgen for use in the Neulasta Onpro kit, a delivery system for Amgen's Neulasta. The Omnipod platform offers continuous insulin delivery that provides various benefits of insulin pump therapy in a way without the need for external tubing required with conventional pumps. The small, lightweight, self-adhesive disposable tubeless Omnipod device (Pod), can be worn in multiple locations, including the abdomen, hip, back of upper arm, upper thigh, or lower back, and delivers insulin into the body through a small flexible tube. Omnipod 5 includes an AID algorithm embedded in the Pod.

Company Info

INSULET CORP

100 Nagog Park

Acton MASSACHUSETTS 01720 US

CEO: Shacey Petrovic

Employees: 3900

PODD Company Website

PODD Investor Relations

Phone: 19786007000

INSULET CORP / PODD FAQ

What is the stock price of INSULET CORP today?

The current stock price of PODD is 331.79 USD. The price decreased by -0.01% in the last trading session.


What is the ticker symbol for INSULET CORP stock?

The exchange symbol of INSULET CORP is PODD and it is listed on the Nasdaq exchange.


On which exchange is PODD stock listed?

PODD stock is listed on the Nasdaq exchange.


What is the price forecast or stock price prediction for INSULET CORP stock?

32 analysts have analysed PODD and the average price target is 359.23 USD. This implies a price increase of 8.27% is expected in the next year compared to the current price of 331.79. Check the INSULET CORP stock analysts ratings, price target forecast and up-and down grades for more detailed information.


What is INSULET CORP worth?

INSULET CORP (PODD) has a market capitalization of 23.35B USD. This makes PODD a Large Cap stock.


How many employees does INSULET CORP have?

INSULET CORP (PODD) currently has 3900 employees.


What are the support and resistance levels for INSULET CORP (PODD) stock?

INSULET CORP (PODD) has a support level at 284.63 and a resistance level at 331.84. Check the full technical report for a detailed analysis of PODD support and resistance levels.


Is INSULET CORP (PODD) expected to grow?

The Revenue of INSULET CORP (PODD) is expected to grow by 27.61% in the next year. Check the estimates tab for more information on the PODD EPS, Sales, EBIT and EBITDA future analyst estimates.


Should I buy INSULET CORP (PODD) stock?

There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:


Does INSULET CORP (PODD) stock pay dividends?

PODD does not pay a dividend.


When does INSULET CORP (PODD) report earnings?

INSULET CORP (PODD) will report earnings on 2025-11-05, after the market close.


What is the Price/Earnings (PE) ratio of INSULET CORP (PODD)?

The PE ratio for INSULET CORP (PODD) is 78.44. This is based on the reported non-GAAP earnings per share of 4.23 and the current share price of 331.79 USD. Check the full fundamental report for a full analysis of the valuation metrics for PODD.


What is the Short Interest ratio of INSULET CORP (PODD) stock?

The outstanding short interest for INSULET CORP (PODD) is 2.5% of its float. Check the ownership tab for more information on the PODD short interest.


PODD Technical Analysis

ChartMill assigns a technical rating of 10 / 10 to PODD. When comparing the yearly performance of all stocks, PODD is one of the better performing stocks in the market, outperforming 87.22% of all stocks.


Chartmill TA Rating
Chartmill Setup Rating

PODD Fundamental Analysis

ChartMill assigns a fundamental rating of 7 / 10 to PODD. While PODD has a great profitability rating, there are some minor concerns on its financial health.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend

PODD Financial Highlights

Over the last trailing twelve months PODD reported a non-GAAP Earnings per Share(EPS) of 4.23. The EPS increased by 24.78% compared to the year before.


Industry RankSector Rank
PM (TTM) 10.01%
ROA 6.81%
ROE 16.14%
Debt/Equity 0.64
Chartmill High Growth Momentum
EPS Q2Q%112.73%
Sales Q2Q%32.88%
EPS 1Y (TTM)24.78%
Revenue 1Y (TTM)25.99%

PODD Forecast & Estimates

32 analysts have analysed PODD and the average price target is 359.23 USD. This implies a price increase of 8.27% is expected in the next year compared to the current price of 331.79.

For the next year, analysts expect an EPS growth of 42.06% and a revenue growth 27.61% for PODD


Analysts
Analysts84.38
Price Target359.23 (8.27%)
EPS Next Y42.06%
Revenue Next Year27.61%

PODD Ownership

Ownership
Inst Owners103.01%
Ins Owners0.28%
Short Float %2.5%
Short Ratio2.42